跳至主要内容
临床试验/CTRI/2022/02/040171
CTRI/2022/02/040171尚未招募2 期

CONTROLLED STUDY OF MUSTAKATUKA CHURNA IN RASA RAKTAGAT MEDO DUSHTI W.S.R. TO DYSLIPIDEMIA

Dr Akanksha Dandekar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • newly diagnosed dyslipidemia patients
  • Lipid Panel:
  • SR. NO. LIPID PANEL BORDERLINE
  • 1 Total Cholesterol 200 to 293 mg/dl
  • 2 LDL-C 130 to 159 mg /dl
  • 3 HDL-C 35 to 45 mg/dl
  • 4 Triglycerides 150-199 mg/dl

排除标准

  • Age: <30, >75yrs
  • Pregnant women & lactating mothers.
  • Patients having history of serious cardiac disorders like myocardial
  • infarction, cardiac failure, COPD.
  • Untreated thyroid disorder.
  • Patients having any major illness like uncontrolled diabetes mellitus.
  • Known case of Asthma, neurological disorders, anemia (Hb <10mg/dl).
  • Known case of Renal insufficiency, nephrotic syndrome.
  • Known case of severe Liver diseases.
  • Known case of HIV positive and HbsAg positive patients.
  • Immune compromised patients.
  • Any serious medical and psychological condition subjects will not be
  • Blood Lipid profile according to NCEP -According to Adult Treatment
  • SR. NO. LIPID PANEL DESIRABLE HIGH RISK
  • 1 Total Cholesterol < 200 mg /dl >240 mg/dl
  • 2 LDL-C > 130mg/dl 160-189 mg/dl
  • 3 HDL-C - Male
  • < 40 mg/dl
  • < 50 mg/dl
  • 4 Triglycerides >150 mg/dl 200-499 mg/dl

研究者

发起方
Dr Akanksha Dandekar

相似试验